Suppr超能文献

经肛门冲洗治疗难治性慢性特发性便秘:患者认为这是一种安全有效的治疗方法。

Transanal Irrigation for Refractory Chronic Idiopathic Constipation: Patients Perceive a Safe and Effective Therapy.

作者信息

Etherson Kevin J, Minty Ian, Bain Iain M, Cundall Jeremy, Yiannakou Yan

机构信息

Department of Colorectal Surgery, County Durham and Darlington NHS Foundation Trust, Durham, UK.

Department of Radiology, County Durham and Darlington NHS Foundation Trust, Durham, UK.

出版信息

Gastroenterol Res Pract. 2017;2017:3826087. doi: 10.1155/2017/3826087. Epub 2017 Jan 1.

Abstract

Transanal irrigation (TAI) can successfully treat neurogenic bowel dysfunction (NBD), but patient perception of its use in chronic idiopathic constipation (CIC) is unknown. To evaluate patient perceptions of the efficacy and safety of TAI for CIC and whether there are predictive factors of perceived treatment response. Prospective data collection of baseline physiology and symptom severity; retrospective evaluation of efficacy and safety perceptions using a snapshot survey. All patients fulfilling the Rome III criteria for functional constipation with chronic idiopathic aetiology were included. The main outcome measure was the duration of patients' usage of TAI. 102 patients reported 21,476 irrigations over 119 patient years, with a mean duration of therapy use of 60.5 weeks [SD 73.2 : SE 7.3]. Overall symptom improvement included general well-being (65%), rectal clearance (63%), bloating (49%), abdominal pain (48%), and bowel frequency (42%). 68 patients (67%) were "moderately better" or "very much better" on a satisfaction question. Reported complications were minor. No correlation was demonstrated between duration of therapy use and baseline measures. A significant proportion of CIC sufferers use TAI as a long-term or bridging therapy and perceive it as safe. This therapy demands a prospective investigation of efficacy and safety.

摘要

经肛门灌洗(TAI)可成功治疗神经源性肠功能障碍(NBD),但患者对其用于慢性特发性便秘(CIC)的看法尚不清楚。目的是评估患者对TAI治疗CIC的疗效和安全性的看法,以及是否存在预测治疗反应的因素。前瞻性收集基线生理指标和症状严重程度数据;通过快照调查对疗效和安全性看法进行回顾性评估。纳入所有符合罗马III功能性便秘标准且病因是慢性特发性的患者。主要结局指标是患者使用TAI的持续时间。102例患者在119个患者年中报告了21476次灌洗,治疗使用的平均持续时间为60.5周[标准差73.2:标准误7.3]。总体症状改善包括总体幸福感(65%)、直肠清除(63%)、腹胀(49%)、腹痛(48%)和排便频率(42%)。在满意度问题上,68例患者(67%)表示“有所好转”或“明显好转”。报告的并发症轻微。未发现治疗使用持续时间与基线指标之间存在相关性。相当一部分CIC患者将TAI用作长期或过渡性治疗,并认为其安全。这种治疗方法需要对疗效和安全性进行前瞻性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa1f/5237460/399158df5865/GRP2017-3826087.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验